Curevac AG
CureVac AG, a pioneering biopharmaceutical company headquartered in Tübingen, Germany, is at the forefront of mRNA technology. Founded in 2000, CureVac has made significant strides in the development of innovative therapies and vaccines, particularly in the fields of oncology and infectious diseases. The company is renowned for its proprietary mRNA platform, which enables the creation of targeted treatments that harness the body’s own immune response. Notable achievements include the advancement of its COVID-19 vaccine candidate, which showcased the potential of mRNA in rapid vaccine development. With a strong market position and collaborations with leading pharmaceutical companies, CureVac AG continues to drive advancements in the biotechnology sector, aiming to transform the landscape of medicine through its unique approach to mRNA therapeutics.
DitchCarbon Score
How does Curevac AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Curevac AG's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Curevac AG's reported carbon emissions
Curevac AG, headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company operates within the biopharmaceutical sector, which is increasingly focusing on sustainability and reducing carbon footprints. As industry standards evolve, it is expected that Curevac AG will align with emerging climate commitments and best practices to address environmental concerns.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Curevac AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
